Home/Filings/4/0001127602-18-005988
4//SEC Filing

Gary M. Huff 4

Accession 0001127602-18-005988

CIK 0000920148other

Filed

Feb 13, 7:00 PM ET

Accepted

Feb 14, 2:21 PM ET

Size

8.0 KB

Accession

0001127602-18-005988

Insider Transaction Report

Form 4
Period: 2018-02-12
Gary M. Huff
CEO, LabCorp Diagnostics
Transactions
  • Award

    Non-qualified Stock Options

    2018-02-12+6,8006,800 total
    Exercise: $168.49From: 2019-02-12Exp: 2028-02-11Common Stock (6,800 underlying)
  • Award

    Restricted Stock Unit

    2018-02-12+1,76014,721 total
    Common Stock (1,760 underlying)
Footnotes (5)
  • [F1]Employee stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2016 Omnibus Incentive Plan.
  • [F2]The option vests in three equal installments beginning on the date reflected in this column.
  • [F3]Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.
  • [F4]The Restricted Stock Units vest in three equal annual installments beginning on 2/12/2019.
  • [F5]This number reflects the aggregate number of Restricted Stock Units held by the reporting person.

Issuer

LABORATORY CORP OF AMERICA HOLDINGS

CIK 0000920148

Entity typeother
IncorporatedNC

Related Parties

1
  • filerCIK 0001702387

Filing Metadata

Form type
4
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 2:21 PM ET
Size
8.0 KB